The Global Rheumatoid Arthritis Testing Market Report was published by QY Research recently.
Summary
The global Rheumatoid Arthritis Testing market size is projected to reach US$ 34.86 billion by 2028, from US$ 23.18 billion in 2021, at a CAGR of 7.04% during 2022-2028.
Fully considering the economic change by this health crisis, Serological Tests accounting for 50.48% of the Rheumatoid Arthritis Testing global market in 2021, is projected to value US$ 1,663.85 million by 2028, growing at a revised 6.18% CAGR 2022-2028. While Hospitals and Clinics segment is altered to an 5.95% CAGR throughout this forecast period.
North America Rheumatoid Arthritis Testing market size is valued at US$ 817.03 million in 2021, while Europe and Asia Pacific Rheumatoid Arthritis Testing are US$ 574.49 million and US$ 534.39 million, severally. The proportion of the North America is 40.68% in 2021, while Europe and APAC are 28.60% and 26.61% respectively, and it is predicted that APAC proportion will reach 29.69% in 2028, trailing a CAGR of 8.66% through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia. As for the Europe Rheumatoid Arthritis Testing landscape, Germany is projected to reach US$ 222.84 million by 2028 trailing a CAGR of 6.21% from 2022 to 2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Rheumatoid Arthritis Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Rheumatoid Arthritis Testing market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Rheumatoid Arthritis Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Rheumatoid Arthritis Testing market.
Full Report Description, Table of Figure, Chart, Free sample, etc. please click
https://us.qyresearch.com/reports/371062/rheumatoid-arthritis-testing
The report mentions the prominent market player consisting of:
Abbott Laboratories
- Hoffmann-La Roche
Beckman Coulter
Siemens Healthineers
Augurex Life Sciences
Svar Life Science AB
Aviva Systems Biology
Bio-Rad Laboratories
Thermo Fisher Scientific
Microdrop
Werfen
Axis-Shield
Rheumatoid Arthritis Testing Market Segment by Type
Serological Tests
Rheumatoid Arthritis Severity Tests and Medication Monitoring Tests
Ultrasound Diagnosis
Others
Rheumatoid Arthritis Testing Market Segment by Application
Hospitals and Clinics
Diagnostic Centers
Others
The report on the Rheumatoid Arthritis Testing market covers the following region (country) analysis:
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Latin America
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Egypt
Rest of MEA
Key Objectives of This Report
To study and analyze the global Rheumatoid Arthritis Testing consumption (value & volume) by key regions/countries, type and application, history data from 2017 to 2022, and forecast to 2028.
To understand the structure of Rheumatoid Arthritis Testing market by identifying its various subsegments.
Focuses on the key global Rheumatoid Arthritis Testing manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Rheumatoid Arthritis Testing with respect to individual growth trends, prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges, and risks).
To project the consumption of Rheumatoid Arthritis Testing submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
1 Report Overview 1
1.1 Study Scope 1
1.2 Market Analysis by Type 1
1.2.1 Global Rheumatoid Arthritis Testing Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1
1.2.2 Serological Tests 3
1.2.3 Rheumatoid Arthritis Severity Tests and Medication Monitoring Tests 4
1.2.4 Ultrasound Diagnosis 5
1.3 Market by Application 6
1.3.1 Global Rheumatoid Arthritis Testing Market Share by Application: 2017 VS 2021 VS 2028 6
1.3.2 Hospitals and Clinics 7
1.3.3 Diagnostic Centers 8
1.3.4 Others 8
1.4 Study Objectives 9
1.5 Years Considered 10
2 Global Growth Trends 11
2.1 Global Rheumatoid Arthritis Testing Market Perspective (2017-2028) 11
2.2 Rheumatoid Arthritis Testing Growth Trends by Region 12
2.2.1 Rheumatoid Arthritis Testing Market Size by Region: 2017 VS 2021 VS 2028 12
2.2.2 Rheumatoid Arthritis Testing Historic Market Size by Region (2017-2022) 13
2.2.3 Rheumatoid Arthritis Testing Forecasted Market Size by Region (2023-2028) 14
2.3 Rheumatoid Arthritis Testing Market Dynamics 15
2.3.1 Rheumatoid Arthritis Testing Industry Trends 15
2.3.2 Rheumatoid Arthritis Testing Market Drivers 16
2.3.3 Rheumatoid Arthritis Testing Market Challenges 16
2.3.4 Rheumatoid Arthritis Testing Market Restraints 17
3 Competition Landscape by Key Players 18
3.1 Global Top Rheumatoid Arthritis Testing Players by Revenue 18
3.1.1 Global Top Rheumatoid Arthritis Testing Players by Revenue (2017-2022) 18
3.1.2 Global Rheumatoid Arthritis Testing Revenue Market Share by Players (2017-2022) 19
3.2 Global Rheumatoid Arthritis Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 20
3.3 Players Covered: Ranking by Rheumatoid Arthritis Testing Revenue 21
3.4 Global Rheumatoid Arthritis Testing Market Concentration Ratio 22
3.4.1 Global Rheumatoid Arthritis Testing Market Concentration Ratio (CR5 and HHI) 22
3.4.2 Global Top 6 and Top 3 Companies by Rheumatoid Arthritis Testing Revenue in 2021 23
3.5 Rheumatoid Arthritis Testing Key Players Head office and Area Served 24
3.6 Key Players Rheumatoid Arthritis Testing Product Solution and Service 24
3.7 Founded Date of Key Player 25
3.8 Mergers & Acquisitions, Expansion Plans 25
4 Rheumatoid Arthritis Testing Breakdown Data by Type 27
4.1 Global Rheumatoid Arthritis Testing Historic Market Size by Type (2017-2022) 27
4.2 Global Rheumatoid Arthritis Testing Forecasted Market Size by Type (2023-2028) 28
5 Rheumatoid Arthritis Testing Breakdown Data by Application 29
5.1 Global Rheumatoid Arthritis Testing Historic Market Size by Application (2017-2022) 29
5.2 Global Rheumatoid Arthritis Testing Forecasted Market Size by Application (2023-2028) 29
6 North America 31
6.1 North America Rheumatoid Arthritis Testing Market Size (2017-2028) 31
6.2 North America Rheumatoid Arthritis Testing Market Size by Type 31
6.2.1 North America Rheumatoid Arthritis Testing Market Size by Type (2017-2022) 31
6.2.2 North America Rheumatoid Arthritis Testing Market Size by Type (2023-2028) 32
6.2.3 North America Rheumatoid Arthritis Testing Market Share by Type (2017-2028) 32
6.3 North America Rheumatoid Arthritis Testing Market Size by Application 33
6.3.1 North America Rheumatoid Arthritis Testing Market Size by Application (2017-2022) 33
6.3.2 North America Rheumatoid Arthritis Testing Market Size by Application (2023-2028) 33
6.3.3 North America Rheumatoid Arthritis Testing Market Share by Application (2017-2028) 34
6.4 North America Rheumatoid Arthritis Testing Market Size by Country 34
6.4.1 North America Rheumatoid Arthritis Testing Market Size by Country (2017-2022) 34
6.4.2 North America Rheumatoid Arthritis Testing Market Share by Country (2023-2028) 35
6.4.3 United States 36
6.4.4 Canada 36
6.4.5 Mexico 37
7 Europe 38
7.1 Europe Rheumatoid Arthritis Testing Market Size (2017-2028) 38
7.2 Europe Rheumatoid Arthritis Testing Market Size by Type 38
7.2.1 Europe Rheumatoid Arthritis Testing Market Size by Type (2017-2022) 38
7.2.2 Europe Rheumatoid Arthritis Testing Market Size by Type (2023-2028) 39
7.2.3 Europe Rheumatoid Arthritis Testing Market Share by Type (2017-2028) 39
7.3 Europe Rheumatoid Arthritis Testing Market Size by Application 39
7.3.1 Europe Rheumatoid Arthritis Testing Market Size by Application (2017-2022) 39
7.3.2 Europe Rheumatoid Arthritis Testing Market Size by Application (2023-2028) 40
7.3.3 Europe Rheumatoid Arthritis Testing Market Share by Application (2017-2028) 40
7.4 Europe Rheumatoid Arthritis Testing Market Size by Country 41
7.4.1 Europe Rheumatoid Arthritis Testing Market Size by Country (2017-2022) 41
7.4.2 Europe Rheumatoid Arthritis Testing Market Size by Country (2023-2028) 41
7.4.3 Germany 42
7.4.4 France 43
7.4.5 U.K. 43
7.4.6 Italy 44
7.4.7 Spain 44
8 Asia-Pacific 45
8.1 Asia-Pacific Rheumatoid Arthritis Testing Market Size (2017-2028) 45
8.2 Asia-Pacific Rheumatoid Arthritis Testing Market Size by Type 45
8.2.1 Asia-Pacific Rheumatoid Arthritis Testing Market Size by Type (2017-2022) 45
8.2.2 Asia-Pacific Rheumatoid Arthritis Testing Market Size by Type (2023-2028) 46
8.2.3 Asia-Pacific Rheumatoid Arthritis Testing Market Share by Type (2017-2028) 46
8.3 Asia-Pacific Rheumatoid Arthritis Testing Market Size by Application 47
8.3.1 Asia-Pacific Rheumatoid Arthritis Testing Market Size by Application (2017-2022) 47
8.3.2 Asia-Pacific Rheumatoid Arthritis Testing Market Size by Application (2023-2028) 47
8.3.3 Asia-Pacific Rheumatoid Arthritis Testing Market Share by Application (2017-2028) 48
8.4 Asia-Pacific Rheumatoid Arthritis Testing Market Size by Region 48
8.4.1 Asia-Pacific Rheumatoid Arthritis Testing Market Size by Region (2017-2022) 48
8.4.2 Asia-Pacific Rheumatoid Arthritis Testing Market Size by Region (2023-2028) 49
8.4.3 China 50
8.4.4 Japan 50
8.4.5 South Korea 51
8.4.6 Southeast Asia 52
8.4.7 India 52
8.4.8 Australia 53
9 Latin America 54
9.1 Latin America Rheumatoid Arthritis Testing Market Size (2017-2028) 54
9.2 Latin America Rheumatoid Arthritis Testing Market Size by Type 54
9.2.1 Latin America Rheumatoid Arthritis Testing Market Size by Type (2017-2022) 54
9.2.2 Latin America Rheumatoid Arthritis Testing Market Size by Type (2023-2028) 55
9.2.3 Latin America Rheumatoid Arthritis Testing Market Share by Type (2017-2028) 55
9.3 Latin America Rheumatoid Arthritis Testing Market Size by Application 56
9.3.1 Latin America Rheumatoid Arthritis Testing Market Size by Application (2017-2022) 56
9.3.2 Latin America Rheumatoid Arthritis Testing Market Size by Application (2023-2028) 56
9.3.3 Latin America Rheumatoid Arthritis Testing Market Share by Application (2017-2028) 57
9.4 Latin America Rheumatoid Arthritis Testing Market Size by Country 57
9.4.1 Latin America Rheumatoid Arthritis Testing Market Size by Country (2017-2022) 57
9.4.2 Latin America Rheumatoid Arthritis Testing Market Size by Country (2023-2028) 58
9.4.3 Argentina 59
9.4.4 Brazil 59
10 Middle East & Africa 60
10.1 Middle East & Africa Rheumatoid Arthritis Testing Market Size (2017-2028) 60
10.2 Middle East & Africa Rheumatoid Arthritis Testing Market Size by Type 60
10.2.1 Middle East & Africa Rheumatoid Arthritis Testing Market Size by Type (2017-2022) 60
10.2.2 Middle East & Africa Rheumatoid Arthritis Testing Market Size by Type (2023-2028) 61
10.2.3 Middle East & Africa Rheumatoid Arthritis Testing Market Share by Type (2017-2028) 61
10.3 Middle East & Africa Rheumatoid Arthritis Testing Market Size by Application 62
10.3.1 Middle East & Africa Rheumatoid Arthritis Testing Market Size by Application (2017-2022) 62
10.3.2 Middle East & Africa Rheumatoid Arthritis Testing Market Size by Application (2023-2028) 62
10.3.3 Middle East & Africa Rheumatoid Arthritis Testing Market Share by Application (2017-2028) 63
10.4 Middle East & Africa Rheumatoid Arthritis Testing Market Size by Country 63
10.4.1 Middle East & Africa Rheumatoid Arthritis Testing Market Size by Country (2017-2022) 63
10.4.2 Middle East & Africa Rheumatoid Arthritis Testing Market Size by Country (2023-2028) 64
10.4.3 Turkey 65
10.4.4 Saudi Arabia 65
10.4.5 UAE 66
11 Key Players Profiles 67
11.1 Abbott Laboratories 67
11.1.1 Abbott Laboratories Company Details 67
11.1.2 Abbott Laboratories Business Overview 67
11.1.3 Abbott Laboratories Rheumatoid Arthritis Testing Introduction 68
11.1.4 Abbott Laboratories Revenue in Rheumatoid Arthritis Testing Business (2017-2022) 69
11.2 F. Hoffmann-La Roche 70
11.2.1 F. Hoffmann-La Roche Company Details 70
11.2.2 F. Hoffmann-La Roche Business Overview 70
11.2.3 F. Hoffmann-La Roche Rheumatoid Arthritis Testing Introduction 70
11.2.4 F. Hoffmann-La Roche Revenue in Rheumatoid Arthritis Testing Business (2017-2022) 71
11.2.5 F. Hoffmann-La Roche Recent Development 72
11.3 Beckman Coulter 72
11.3.1 Beckman Coulter Company Details 72
11.3.2 Beckman Coulter Business Overview 72
11.3.3 Beckman Coulter Rheumatoid Arthritis Testing Introduction 73
11.3.4 Beckman Coulter Revenue in Rheumatoid Arthritis Testing Business (2017-2022) 74
11.4 Siemens Healthineers 75
11.4.1 Siemens Healthineers Company Details 75
11.4.2 Siemens Healthineers Business Overview 75
11.4.3 Siemens Healthineers Rheumatoid Arthritis Testing Introduction 75
11.4.4 Siemens Healthineers Revenue in Rheumatoid Arthritis Testing Business (2017-2022) 76
11.4.5 Siemens Healthineers Recent Development 76
11.5 Augurex Life Sciences 77
11.5.1 Augurex Life Sciences Company Details 77
11.5.2 Augurex Life Sciences Business Overview 77
11.5.3 Augurex Life Sciences Rheumatoid Arthritis Testing Introduction 78
11.5.4 Augurex Life Sciences Revenue in Rheumatoid Arthritis Testing Business (2017-2022) 78
11.6 Svar Life Science AB 79
11.6.1 Svar Life Science AB Company Details 79
11.6.2 Svar Life Science AB Business Overview 79
11.6.3 Svar Life Science AB Rheumatoid Arthritis Testing Introduction 79
11.6.4 Svar Life Science AB Revenue in Rheumatoid Arthritis Testing Business (2017-2022) 81
11.7 Aviva Systems Biology 82
11.7.1 Aviva Systems Biology Company Details 82
11.7.2 Aviva Systems Biology Business Overview 82
11.7.3 Aviva Systems Biology Rheumatoid Arthritis Testing Introduction 82
11.7.4 Aviva Systems Biology Revenue in Rheumatoid Arthritis Testing Business (2017-2022) 83
11.8 Bio-Rad Laboratories 84
11.8.1 Bio-Rad Laboratories Company Details 84
11.8.2 Bio-Rad Laboratories Business Overview 84
11.8.3 Bio-Rad Laboratories Rheumatoid Arthritis Testing Introduction 84
11.8.4 Bio-Rad Laboratories Revenue in Rheumatoid Arthritis Testing Business (2017-2022) 88
11.8.5 Bio-Rad Laboratories Recent Development 88
11.9 Thermo Fisher Scientific 88
11.9.1 Thermo Fisher Scientific Company Details 88
11.9.2 Thermo Fisher Scientific Business Overview 89
11.9.3 Thermo Fisher Scientific Rheumatoid Arthritis Testing Introduction 89
11.9.4 Thermo Fisher Scientific Revenue in Rheumatoid Arthritis Testing Business (2017-2022) 91
11.9.5 Thermo Fisher Scientific Recent Development 92
11.10 Microdrop 92
11.10.1 Microdrop Company Details 92
11.10.2 Microdrop Business Overview 92
11.10.3 Microdrop Rheumatoid Arthritis Testing Introduction 93
11.10.4 Microdrop Revenue in Rheumatoid Arthritis Testing Business (2017-2022) 93
11.11 Werfen 94
11.11.1 Werfen Company Details 94
11.11.2 Werfen Business Overview 94
11.11.3 Werfen Rheumatoid Arthritis Testing Introduction 95
11.11.4 Werfen Revenue in Rheumatoid Arthritis Testing Business (2017-2022) 95
11.11.5 Werfen Recent Development 96
11.12 Axis-Shield 96
11.12.1 Axis-Shield Company Details 96
11.12.2 Axis-Shield Business Overview 96
11.12.3 Axis-Shield Rheumatoid Arthritis Testing Introduction 97
11.12.4 Axis-Shield Revenue in Rheumatoid Arthritis Testing Business (2017-2022) 99
12 Analyst’s Viewpoints/Conclusions 100
13 Appendix 101
13.1 Research Methodology 101
13.1.1 Methodology/Research Approach 101
13.1.2 Data Source 104
13.2 Disclaimer 107
13.3 Author Details 107
Any questions or further requirements about the report, please click
https://us.qyresearch.com/reports/371062/rheumatoid-arthritis-testing
Customization of the Report:
This report can be customized to meet the client’s requirements. Please contact with us (global@qyresearch.com), who will ensure that you get a report that suits your needs.
Company Profiles:
QYResearch founded in California, USA in 2007. It is a leading global market research and consulting company. With over 15 years’ experience and professional research team in various cities over the world, QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 59,000 clients across five continents. Let’s work closely with you and build a bold and better future.
Contact Us
QY Research
E-mail: global@qyresearch.com
Tel: +1-626-842-1666(US) +852-5808-0956 (HK)
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
Website: https://us.qyresearch.com